| Disease | THE OBJECTIVE OF THE STUDY WAS TO MEASURE THE EFFECTIVENESS OF ANDROGRAPHIS PANICULATA SHA-10 EXTRACT IN REDUCING THE PREVALENCE AND INTENSITY OF SYMPTOMS AND SIGNS OF COMMON COLD AS COMPARED WITH A PLACEBO. A GROUP OF 158 ADULT PATIENTS OF
BOTH SEXES COMPLETED THE RANDOMIZED DOUBLE BLIND STUDY IN VALDIVIA, CHILE. THE PATIENTS WERE DIVIDED IN TWO EQUAL SIZE GROUPS, ONE OF WHICH RECEIVED ANDROGRAPHIS PANICULATA DRIED EXTRACT (1200MG/DAY) AND THE OTHER A PLACEBO DURING A PERIOD
OF 5 DAYS. EVALUATIONS FOR EFFICACY WERE PERFORMED BY THE PATIENTS AT DAY 0,2, AND 4 OF THE TREATMENT; EACH COMPLETED A SELF-EVALUATION (VAS) SHEET WITH THE FOLLOWING PARAMETERS: HEADACHE, TIREDNESS, EARACHE, SLEEPLESSNESS, SORE THROAT, NASAL
SECRETION, PHLEGM, FREQUENCY AND INTENSITY OF COUGH. AT DAY 2 OF TREATMENT OF SIGNIFICANT DECREASE IN THE INTENSITY OF THE SYMPTOMS OF TIREDNESS (OR=1.28; 95% CI 1.07-1.53), SLEEPLESSNESS (OR=1.71; 95% CI 1.38-2.11), SORE THROAT (OR=2.3;
95 RYO CI 1.69-314) AND NASAL SECRETION (OR=2.51; 95% CI 1.82-3.46) WAS OBSERVED IN THE ANDROGRAPHIS SHA-10 GROUPS AS COMPARED WITH THE PLACEBO GROUP. AT DAY 4, A SIGNIFICANT DECREASE IN THE INTENSITY OF ALL SYMPTOMS WAS OBSERVED FOR THE
ANDROGRAPHIS PANICULATA GROUP. THE HIGHER OR VALUES WERE FOR THE FOLLOWING PARAMETERS: SORE THROAT (OR=3.59; 95 RYO CI 2.04-5.35), NASAL SECRETION (OR=3.27; 95 RYO CI 2.31-4.62) AND EARACHE (OR=3.11; 95 RYO CI 2.01-4.80) FOR ANDROGRAPHIS
PANICULATA TREATMENT OVER PALCEBO, RESPECTIVELY. IT IS CONCLUDED THAT ANDROGRPAHIS PNAICULATA HAD A HIGH DEGREE OF EFFECTIVENESSI I REDUCING THE PREVALENCE AND INTENSITY OF THE SYMPTOMS IN UNCOMPLICATED COMMON COLD BEGINNING AT DAY TWO OF
TREATMENT. NO ADVERSE EFFECTS WERE OBSERVED OR REPORTED. |